Ligand Pharmaceuticals (LGND) Amortization - Intangibles (2015 - 2026)
Ligand Pharmaceuticals (LGND) posted Amortization - Intangibles of $8.1 million for Q1 2026, little changed sequentially from $8.1 million in Q4 2025, and down 1.94% YoY from $8.3 million in Q1 2025.
Ligand Pharmaceuticals (LGND) Amortization - Intangibles (2015 - 2026) Analysis & Trends
Ligand Pharmaceuticals has reported Amortization - Intangibles for 12 years, with the latest figure at $8.1 million in Q1 2026.
- Quarterly Amortization - Intangibles fell 1.94% year-over-year to $8.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $32.5 million (down 1.61% YoY) and the FY2025 annual result came in at $32.7 million, down 0.91% from the prior year.
- Amortization - Intangibles was little changed at $8.1 million in Q1 2026 per LGND's latest filing, from $8.1 million in the prior quarter.
- Over five years, Amortization - Intangibles peaked at $8.6 million in Q1 2022 and troughed at $8.1 million in Q4 2025.
- A 5-year average of $8.3 million and a median of $8.3 million in 2024 frame the typical range for Amortization - Intangibles.
- The widest YoY moves for Amortization - Intangibles: up 830.45% in 2022, down 27.56% in 2022.
- Over 5 years, Amortization - Intangibles stood at $8.5 million in 2022, then dropped by 2.35% to $8.3 million in 2023, then fell by 0.47% to $8.3 million in 2024, then decreased by 2.54% to $8.1 million in 2025, then climbed by 0.11% to $8.1 million in 2026.
- According to Business Quant data, Amortization - Intangibles over the past three periods registered $8.1 million, $8.1 million, and $8.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Ligand Pharmaceuticals | 5.87 Bn | 4.51 Bn | 60.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.10 Mn |
| Mar 31, 2026 | 8.10 Mn |
| Dec 31, 2025 | 8.09 Mn |
| Sep 30, 2025 | 8.10 Mn |
| Jun 30, 2025 | 8.26 Mn |
| Mar 31, 2025 | 8.26 Mn |
| Dec 31, 2024 | 8.30 Mn |
| Sep 30, 2024 | 8.26 Mn |
| Jun 30, 2024 | 8.26 Mn |
| Mar 31, 2024 | 8.19 Mn |
| Dec 31, 2023 | 8.34 Mn |
| Sep 30, 2023 | 8.24 Mn |
| Jun 30, 2023 | 8.54 Mn |
| Mar 31, 2023 | 8.54 Mn |
| Dec 31, 2022 | 8.54 Mn |
| Sep 30, 2022 | 8.57 Mn |
| Jun 30, 2022 | 8.55 Mn |
| Mar 31, 2022 | 8.58 Mn |
| Dec 31, 2021 | -1.17 Mn |
| Sep 30, 2021 | 11.83 Mn |